Clinical Trial Update: Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy

View source ↗

Summary

Clinical study examining skeletal muscle biomarkers in people with Fragile Sarcolemmal Muscular Dystrophy; sponsored by NICHD, currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Sarcolemmal Muscular Dystrophy

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Genetic Disorder | Status: ACTIVE_NOT_RECRUITING